Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

New Therapy Aids Bid to Beat Organ Failure Caused by Pancreatitis

January 12, 2016 8:30 am | by University of Edinburgh | News | Comments

Patients suffering organ failure caused by a common inflammatory condition could be helped by a new therapy. Read more...

TOPICS:

Pfizer Expands R&D Equity Investment Strategy to Access Early-Stage Scientific Innovations

January 12, 2016 8:29 am | News | Comments

Pfizer Inc. announced an expansion of its Research & Development (R&D) investment strategy to include early-stage companies on the leading edge of scientific innovation, providing them with both equity and access to resources for research in promising areas aligned with Pfizer’s core interests. Read more...

TOPICS:

Researchers Reveal Mechanisms of How Body Remembers, Fights Infections

January 12, 2016 8:29 am | by Virginia Tech | News | Comments

Scientists at the Virginia Tech Carilion Research Institute have found a potential way to influence long-term memory formation in the immune system. The researchers published their results today in Nature Communications. Read more...

TOPICS:
Advertisement

Potential Heart Disorder Cause, Treatment Identified

January 12, 2016 8:28 am | by University of Guelph | News | Comments

A novel therapy being tested for treating a fatal heart disorder in dogs might ultimately help in diagnosing and treating heart disease in humans. Read more...

TOPICS:

Roche Announces Updated Results for Atezolizumab in Advanced Bladder Cancer

January 12, 2016 8:27 am | News | Comments

Roche is planning to submit these data imminently to Global health authorities and the U.S. Food and Drug Administration (FDA) under Breakthrough Therapy designation. Read more...

TOPICS:

Illumina Taking a Stab at Early-Stage Cancer Detection Test

January 11, 2016 1:06 pm | by Greg Watry, Digital Reporter | News | Comments

Over the weekend, the San Diego-based Illumina announced that its blood tests should reach the market by 2019, and cost around $1,000 or less. Read more...

TOPICS:

New Coalition Forms to Fight Cancer

January 11, 2016 12:15 pm | by Ryan Bushey, Associate Editor | News | Comments

All participants will work together to enroll 20,000 patients in a large swath of clinical trials by the year 2020. Read more...

TOPICS:

Shire, Baxalta Agree to $31 Billion Merger

January 11, 2016 10:55 am | by Ryan Bushey, Associate Editor | News | Comments

Both companies currently have 60 drugs in development. Read more...

TOPICS:
Advertisement

AbbVie: Phase 3 Clinical Trial Launch Evaluating Selective JAK1 Inhibitor, for RA Treatment

January 11, 2016 10:38 am | News | Comments

AbbVie, a global biopharmaceutical company, today announced the start of a large Phase 3 clinical trial program to study the use of ABT-494, an investigational, once-daily, oral selective JAK1 inhibitor for the treatment of rheumatoid arthritis (RA). Read more...

TOPICS:

New Mechanism

January 11, 2016 10:29 am | by Harvard University | News | Comments

A new study from researchers at Harvard Medical School and Massachusetts Eye and Ear showed that in some cases of vestibular schwannoma, a potentially lethal tumor often associated with neurofibromatosis 2 (NF2), secretions from the tumor contain toxic molecules that damage the inner ear. Read more...

TOPICS:

Pfizer Raises Prices for 105 Drugs on New Year's Day

January 11, 2016 9:55 am | by Ryan Bushey, Associate Editor | News | Comments

No price reductions were reported. This news comes on the heels of Pfizer’s planned merger with Dublin, Ireland-based Allergan. Read more...

TOPICS:

Chinese Woman Dies of H5N6 Bird Flu, Another Woman Critical

January 11, 2016 8:15 am | by The Associated Press | News | Comments

 Health authorities in southern China said Tuesday that a 26-year-old woman has died of a strain of bird flu, and another woman is reportedly in serious condition. Read more...

TOPICS:

BRCA1 Deficiency Increases Sensitivity of Ovarian Cancer Cells to Auranofin

January 11, 2016 8:00 am | by Plymouth University | News | Comments

Auranofin is currently undergoing trials for repurposing to treat recurrent epithelial ovarian cancer, which makes up around 90 per cent of diagnosed ovarian cancers. Read more...

TOPICS:

Ebola Medical Team Develops Guidelines for Treating Infected Children

January 11, 2016 7:45 am | by Washington University in St. Louis | News | Comments

When the Ebola virus outbreak erupted in West Africa in 2014, children infected with the virus -- particularly those under age 5 -- faced overwhelming challenges. Read more...

TOPICS:

Mylan Launches Generic Ortho Tri-Cyclen Lo Tablets

January 11, 2016 7:30 am | News | Comments

The product is indicated for the prevention of pregnancy. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading